Pamela Leal Rojas

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

Jan-Bart M. Koorstra, Collins Karikari, Georg Feldmann et al. · Cancer Biology & Therapy · 2009 · 204 citations · Full text

Medicine, Cancer Biology, Oncology +17

Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling

Sneha M. Pinto, Raja Sekhar Nirujogi, Pamela Leal Rojas et al. · PROTEOMICS · 2014 · 73 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse et al. · Oncotarget · 2016 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +11

Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy

Héctor M. Álvarez, Pamela Leal Rojas, Ken‐Tye Yong et al. · Nanomedicine Nanotechnology Biology and Medicine · 2008 · 23 citations

Medicine, Oncology, Pathology +11

Melanoma Hyperpigmentation Is Strongly Associated With KIT Alterations

Julie M. Wu, Héctor Álvarez, Patricia García et al. · American Journal of Dermatopathology · 2009 · 14 citations

Medicine, Dermatology, Pathology +17